ESC Premium Access

Thromboembolic prevention after TAVI: antiplatelets or anticoagulants? Positioning of the topic

Congress Presentation

About the speaker

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)
53 presentations
12 followers

4 more presentations in this session

All we need are antiplatelet agents – PRO

Speaker: Doctor A. Colombo (Milan, IT)

Thumbnail

All we need are antiplatelet agents – CON

Speaker: Professor L. Sondergaard (Copenhagen, DK)

Thumbnail

All we need are antiplatelet agents – Discussion PRO/CONTRA.

Thumbnail

Thromboembolic prevention after TAVI: antiplatelets or anticoagulants? - Conclusion

Speaker: Professor S. Windecker (Bern, CH)

Thumbnail

Access the full session

Thromboembolic prevention after TAVI: antiplatelets or anticoagulants?

Speakers: Professor R. Mehran, Doctor A. Colombo, Professor L. Sondergaard, Professor S. Windecker
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations